QUOTED. 7 June 2019. Rebecca Parkes.
Glooko, a leader in diabetes management data, and T1D Exchange, a nonprofit research group, have formed a collaborative agreement to use Glooko's platform to link anonymized diabetes device data from tens of thousands of type 1 diabetes patients with patients' electronic health-care records. See what T1D's Rebecca Parkes said about it here.
"We will be able to use these comprehensive data analytics to ultimately expand outcome measures for T1D [type 1 diabetes] and move beyond A1c [a blood test that reflects average blood glucose levels], informing our effort and mission to improve outcomes for people living with the disease." – Rebecca Parkes, interim chief operating officer, T1D Exchange
- Find out more: Glooko And T1D Exchange Enter Partnership To Leverage Device Data From Type 1 Diabetics
Click here for a free trial of Medtech Insight